Founded a fractional-executive consultancy focused on driving business impact for customers across healthcare, including clients Illumina, Geisinger Health, Genomics England, AltheaDx, Helix, Modular Medical, Exact Sciences, and more, validating and framing for action commercialization strategy, business development, and product design. Successes include:- Numerous business model redesigns, driving fundraising and sales acceleration- Focused purchase journey optimizations, removing sales barriers and driving commercial impact- Product and portfolio rearchitectures, simplifying go-to-market and unlocking adoption

Established and led Product Experience, Marketing, & Product Management teams. Global responsibility for all Real World Data and Real World Evidence services for life sciences and health systems businesses, serving customers Amgen, Roche, Pfizer, Henry Ford Health Systems, Aurora, and more. Successes included:- Validated and framed company's first global portfolio, with double-digit CAGR- Launched RWD/RWE solution for FDA submission in 4 months, sales exceeded forecast- Unlocked clinical trial patient matching adoption, increasing usage in 30 days

Founded and led Product Experience, Marketing, and Product Management teams. Global responsibility for all adoption and offerings, including Pharma, Clinical, Consumer, and Population. Successes included:- Grew rare disease business to 200 patients/week, with triple-digit revenue CAGR- Shifted business model from product to genomics platform, $240M fundraising resulted- Pioneered methodology to remove barriers in pharma purchase journey, time-to-close reduced 32%- Launched 6 new offerings, four of which defined & developed in under 5 months

Founded and grew the life sciences and genomics practice P&L. Clients included Illumina, Myriad, Foundation Medicine, and LabCorp. The practice became 14% of overall firm revenue within 18 months.

Developed three new businesses in mobile health, mobile commerce, and mobile image recognition/search. Each forecasted in excess of $300 million in annual revenue.

Market validated and launched new businesses, including mobile health, mobile commerce, wireless charging, and indoor positioning. Each forecasted in excess of $500 million. Several patents issued.

Initial database-integration solutions launched in CRM and Life Sciences markets. Raised $1.5M in funding. Established initial revenue stream, completed core technology platform.

Managed $450 million TurboTax product line, including all online and desktop offerings for more than 20 million end users annually. Compounded annual revenue growth of 23% during tenure.